All delays before radiotherapy risk progression of Merkel cell carcinoma

Australasian Radiology

Volumn 48, Issue 3, 2004, Pages 371-375

  Tsang, G ^a   O'Brien, P ^a   Robertson, R ^a   Hamilton, C ^a   Wratten, C ^a   Denham, J ^a  

^a NEWCASTLE MATER HOSPITAL   (Australia)

Author keywords

Chemotherapy; Delay; Merkel cell carcinoma; Radiotherapy; Waiting list

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; MERKEL CELL TUMOR; PRIORITY JOURNAL; TREATMENT OUTCOME;

CARCINOMA, MERKEL CELL; DISEASE PROGRESSION; FEMALE; HEALTH PRIORITIES; HUMANS; MALE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SKIN NEOPLASMS; TIME FACTORS; WAITING LISTS;

EID: 7044226517     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0004-8461.2004.01321.x     Document Type: Article

References (17)

1. Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002; 20: 588-98.
2. Cheuk W, Kwan MY, Suster S, Chan JKC. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma for merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinoma. Arch Pathol Lab Med 2001; 125: 228-31.
3. Poulsen M, Rischin D, Walpole E et al. Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study - TROG 96.07. Int J Radiat Oncol Biol Phys 2001; 51: 156-63.
4. Smith DF, Messina JL, Perrott R et al. Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Cancer Control 2000; 7: 72-83.
5. Haag ML, Glass CF, Fenske NA. Merkel cell carcinoma diagnosis and treatment. Dermatol Surg 1995; 21: 669-83.
6. Boyle F, Pendlebury S, Bell D. Further insights into the natural history and management of primary cutaneous neuroendocrine (merkel cell) carcinoma. Int J Radiat Oncol Biol Phys 1995; 31: 315-23.
7. Poulsen M, Harvey J. Is there a diminishing role for surgery for merkel cell carcinoma of the skin? A review of current management. ANZ J Surg 2002; 72: 142-6.
8. Ott MJ, Tanabe KK, Gadd MA et al. Multimodality management of merkel cell carcinoma. Arch Surg 1999; 134: 388-93.
9. Meeuwissen JA, Bourne RG, Kearsley JH. The importance of postoperative radiation therapy in the treatment of merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1995; 31: 325-31.
10. Morrison WH, Peters LJ, Silva EG, Wendt CD, Kian Ang K, Goepfert H. The essential role of radiation therapy in securing locoregional control of merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1990; 190: 583-91.
11. Fenig E, Brenner B, Katz A, Rakovsky E, Bar Hana M, Sulkes A. The role of radiation therapy and chemotherapy in the treatment of merkel cell carcinoma. Cancer 1997; 80: 881-5.
12. Feun LG, Savaraj N, Legha SS, Silva EG, Benjamin RS, Burgell MA. Chemotherapy for metastatic merkel cell carcinoma: review of the MD Anderson Hospital's experience. Cancer 1988; 62: 683-5.
13. Wynne CJ, Kearsley JH. Merkel cell tumour. A chemosensitive skin cancer. Cancer 1988; 62: 28-31.
14. Seel M, Foroudi F. Waiting for radiation therapy: does it matter? Australas Radiol 2002; 46: 275-9.
15. Huang J, Barbera L, Brouwers M, Browman G, Mackillop WJ. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol 2003; 21: 555-63.
16. 1 nasopharyngeal carcinoma: the effect of waiting time on tumour control. Int J Radiat Oncol Biol Phys 1994; 30: 1111-17.
17. Vikram B. Importance of the time interval between surgery and postoperative radiation therapy in the combined management of head and neck cancer. Int J Radiat Oncol Biol Phys 1979; 5: 1837-40.